EUVIMEDEUVIMED entdecken
Fallbericht

Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis

Sabine Lieb, Maria Heni, Sophie Rauschenberg, Kay Lange, Juergen Feisthammel, Hendrik Bläker, Johannes Wiegand

Zeitschrift für Gastroenterologie · 01.11.2023 · 61 (11) · 1500-1503

DOI: 10.1055/a-2008-0979 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.11.2023. Verfasst von Sabine Lieb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Hepatology, University of Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: Multiple Sclerosis, Colitis, Cytomegalovirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocrelizumab is a humanized monoclonal antibody against the B-lymphocyte antigen CD20 and the only approved treatment option in primary progressive multiple sclerosis. Herpesvirus-related infections like cytomegalovirus (CMV) infections are common in patients receiving ocrelizumab, whereas gastrointestinal side effects with inflammatory bowel disease (IBD) like esophagitis or colitis are very rare. This case report describes the challenging clinical, endoscopic, and histologic features of an ocrelizumab-induced colitis overlapping with CMV infection and their disadvantageous interaction with the underlying multiple sclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisColitisCytomegalovirus InfectionsHumansAntibodies, Monoclonal, Humanized

Substanzen

ocrelizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Dept. of Hepatology, University of Leipzig, Leipzig, Germany.
  • Dept. of Gastroenterology, University of Leipzig, Leipzig, Germany.
  • Helios Klinik Leisnig, Leisnig, Germany.
  • Institute of Pathology, University of Leipzig, Leipzig, Germany.

Zitieren

APA

Lieb, S., Heni, M., Rauschenberg, S., Lange, K., Feisthammel, J., Bläker, H., & Wiegand, J. (2023). Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis. Zeitschrift für Gastroenterologie, 61(11), 1500-1503. https://doi.org/10.1055/a-2008-0979

Vancouver

Lieb S, Heni M, Rauschenberg S, Lange K, Feisthammel J, Bläker H, et al. Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis. Zeitschrift für Gastroenterologie. 2023;61(11):1500-1503. doi:10.1055/a-2008-0979

BibTeX
@article{Lieb2023,
  author = {Lieb, Sabine and Heni, Maria and Rauschenberg, Sophie and Lange, Kay and Feisthammel, Juergen and Bläker, Hendrik and Wiegand, Johannes},
  title = {Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2023},
  volume = {61},
  number = {11},
  pages = {1500--1503},
  doi = {10.1055/a-2008-0979}
}
Kostenlos starten →